Wan X, Wang T, Yang J, Yang X, Li W, Ding L, Yang L, Zhang J, Su M, An K, Zhou Z, Li Y, Wang X, Zhu H, Luo C, Gu L, Chen J, Song L, Tang Y, Li B. Durable remission achieved in pediatric patients with <i>TCF3-HLF</i&gt;-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapy. Haematologica; https://doi.org/10.3324/haematol.2024.287023 [Early view].